4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-001179
Executive VP, CFO & COO bought 1,250 shares at an average $4.04 ($5,045)
From the SEC's structured data for this filing
Trades in this filing
Marvin Donald · Executive VP, CFO & COO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-14 | Purchase : show line 1 in the form | +250 | $4.00 | $1,000 | 250 | D |
| 2022-03-14 | Purchase : show line 2 in the form | +250 | $3.98 | $995 | 500 | D |
| 2022-03-14 | Purchase : show line 3 in the form | +250 | $3.90 | $975 | 1,000 | D |
| 2022-03-14 | Purchase : show line 4 in the form | +250 | $4.10 | $1,025 | 1,250 | D |
| 2022-03-14 | Purchase : show line 5 in the form | +250 | $4.20 | $1,050 | 1,500 | D |
| Open-market purchases · 1,250 sh · avg $4.04 · $5,045 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-08 | Grant or award : show line 6 in the form Option to Purchase American Depositary Shares | +196,875 | 196,875 | D |
Loading xslF345X03/ownership.xml…